Inventor

Lawrence G. Hamann

Inventor
North Grafton, MA, US

Overview

65→
Patents
1997–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 65 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
9,758,487'Hepatitis C virus inhibitors'20179,227,961'Hepatitis C virus inhibitors'20169,193,725'Cyclic hydrazine derivatives as HIV attachment inhibitors'20159,018,390'Hepatitis C virus inhibitors'20158,846,023'Hepatitis C virus inhibitors'20148,822,444'Hepatitis C virus inhibitors'20148,809,548'Hepatitis C virus inhibitors'20148,685,982'Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors'20148,642,025'Hepatitis C virus inhibitors'20148,574,563'Hepatitis C virus inhibitors'20138,546,394'Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors'20138,492,553'Hepatitis C virus inhibitors'2013RE044186'Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method'20138,303,944'Hepatitis C virus inhibitors'20128,288,562'Hepatitis C virus inhibitors'20128,278,462'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20128,242,124'Diketopiperidine derivatives as HIV attachment inhibitors'20128,158,648'Heteroaryl 11-beta hydroxysteroid dehydrogenase type I inhibitors'20128,147,818'Hepatitis C virus inhibitors'20128,148,396'Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors'20128,124,615'Diketo substituted pyrrolo[2,3-C]pyridines'20128,093,243'Hepatitis C virus inhibitors'20127,989,640'Sulfonylpyrrolidine modulators of androgen receptor function and method'20117,960,406'Diketo substituted pyrrolo[2,3-c] pyridines'20117,820,702'Sulfonylpyrrolidine modulators of androgen receptor function and method'20107,807,676'Diketo-Piperazine and Piperidine derivatives as antiviral agents'20107,772,267'Bicyclic modulators of androgen receptor function'20107,759,495'Hepatitis C virus inhibitors'20107,745,636'Hepatitis C virus inhibitors'20107,741,347'Hepatitis C virus inhibitors'20107,732,480'Bicyclic compounds as modulators of androgen receptor function and method'20107,705,033'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20107,704,992'Hepatitis C virus inhibitors'20107,696,241'Bicyclic compounds as modulators of androgen receptor function and method'20107,659,270'Hepatitis C virus inhibitors'20107,635,699'Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods'20097,632,858'Open chain prolyl urea-related modulators of androgen receptor function'20097,625,923'Bicyclic modulators of androgen receptor function'20097,589,088'Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods'20097,579,360'Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors'20097,572,807'Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors'20097,521,557'Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods'20097,488,725'Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods'20097,420,079'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20087,405,234'Bicyclic modulators of androgen receptor function'20087,388,027'Bicyclic compounds as modulators of androgen receptor function and method'20087,256,208'Monocyclic N-Aryl hydantoin modulators of androgen receptor function'20076,995,180'Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods'20066,995,183'Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods'20066,992,102'Bicyclic modulators of androgen receptor function'20066,846,836'N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase'20056,696,459'Steroid receptor modulator compounds and methods'20046,670,386'Bicyclic modulators of androgen receptor function'20036,667,313'8-substituted-6-triflouromethyl-9-pyrido 3,2-G quinoline compounds as androgen receptor modulators'20036,593,493'RXR modulators with improved pharmacologic profile'20036,534,516'Androgen receptor modulator compounds and methods'20036,395,767'Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method'20026,121,450'Intermediates for preparation of steroid receptor modulator compounds'20006,017,924'Androgen receptor modulator compounds and methods'20005,808,139'Non-steroid progesterone receptor agonist and antagonist and compounds and methods'19985,696,133'Steroid receptor modulator compounds and methods'19975,696,130'Tricyclic steroid receptor modulator compounds and methods'19975,693,647'Steroid receptor modulator compounds and methods'19975,688,808'Steroid receptor modulator compounds and methods'19975,677,336'Non-steroid androgen receptor antagonist compounds and methods'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2004Patents assigned to LIGAND PHARM INC (12)· patent assignee history
1997–2004Based in San Diego, CA, US· patent location history
2000Based in Solana Beach, CA, US· patent location history
2002–2017Patents assigned to BRISTOL MYERS SQUIBB CO (52)· patent assignee history
2002–2010Based in Cherry Hill, NJ, US· patent location history
2007–2017Based in North Grafton, MA, US· patent location history
2012–2014Patents assigned to HAMANN LAWRENCE G (16)· patent assignee history
2012–2014Patents assigned to BELEMA MAKONEN (8)· patent assignee history
2012–2014Patents assigned to LOPEZ OMAR D (8)· patent assignee history
2013Based in Cambridge, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO522002–2017
HAMANN LAWRENCE Gself162012–2014
LIGAND PHARM INC121997–2004
BELEMA MAKONEN82012–2014
LOPEZ OMAR D82012–2014
Locations
LocationPatentsSpan
North Grafton, Massachusetts, US352007–2017
Cherry Hill, New Jersey, US192002–2010
San Diego, California, US91997–2004
Cambridge, Massachusetts, US12013
Solana Beach, California, US12000